nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—head and neck cancer—sarcoma	0.328	0.55	CtDrD
Fluorouracil—skin cancer—sarcoma	0.268	0.45	CtDrD
Fluorouracil—ABCC3—Vincristine—sarcoma	0.0441	0.181	CbGbCtD
Fluorouracil—ABCC3—Etoposide—sarcoma	0.0404	0.166	CbGbCtD
Fluorouracil—ABCG2—Dactinomycin—sarcoma	0.0294	0.121	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—sarcoma	0.0275	0.113	CbGbCtD
Fluorouracil—ABCG2—Mitoxantrone—sarcoma	0.0263	0.108	CbGbCtD
Fluorouracil—ABCG2—Vincristine—sarcoma	0.0181	0.0744	CbGbCtD
Fluorouracil—ABCG2—Etoposide—sarcoma	0.0166	0.0682	CbGbCtD
Fluorouracil—CYP1A2—Dacarbazine—sarcoma	0.014	0.0575	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—sarcoma	0.0113	0.0465	CbGbCtD
Fluorouracil—CYP2C8—Etoposide—sarcoma	0.00884	0.0363	CbGbCtD
Fluorouracil—CYP1A2—Etoposide—sarcoma	0.00684	0.0281	CbGbCtD
Fluorouracil—DPYD—mammary gland—sarcoma	0.00145	0.0303	CbGeAlD
Fluorouracil—UMPS—Fluoropyrimidine Activity—SMUG1—sarcoma	0.00143	0.0592	CbGpPWpGaD
Fluorouracil—UPP1—Fluoropyrimidine Activity—SMUG1—sarcoma	0.00133	0.055	CbGpPWpGaD
Fluorouracil—UPP2—Fluoropyrimidine Activity—SMUG1—sarcoma	0.00133	0.055	CbGpPWpGaD
Fluorouracil—UPP1—myometrium—sarcoma	0.00127	0.0265	CbGeAlD
Fluorouracil—UMPS—hematopoietic system—sarcoma	0.00119	0.0248	CbGeAlD
Fluorouracil—UPP1—seminal vesicle—sarcoma	0.00115	0.0239	CbGeAlD
Fluorouracil—UPP2—liver—sarcoma	0.00109	0.0227	CbGeAlD
Fluorouracil—TYMP—endothelium—sarcoma	0.00104	0.0218	CbGeAlD
Fluorouracil—UPP1—skin of body—sarcoma	0.000947	0.0198	CbGeAlD
Fluorouracil—PPAT—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000919	0.0381	CbGpPWpGaD
Fluorouracil—DPYD—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000919	0.0381	CbGpPWpGaD
Fluorouracil—UMPS—uterus—sarcoma	0.000898	0.0188	CbGeAlD
Fluorouracil—PPAT—myometrium—sarcoma	0.000892	0.0186	CbGeAlD
Fluorouracil—TYMP—mammary gland—sarcoma	0.000841	0.0176	CbGeAlD
Fluorouracil—UPP1—cardiac atrium—sarcoma	0.000827	0.0173	CbGeAlD
Fluorouracil—UPP1—uterus—sarcoma	0.000823	0.0172	CbGeAlD
Fluorouracil—PPAT—seminal vesicle—sarcoma	0.000806	0.0168	CbGeAlD
Fluorouracil—MTHFR—mammary gland—sarcoma	0.000791	0.0165	CbGeAlD
Fluorouracil—UMPS—bone marrow—sarcoma	0.000762	0.0159	CbGeAlD
Fluorouracil—UPP1—tendon—sarcoma	0.000721	0.0151	CbGeAlD
Fluorouracil—ABCC5—mammary gland—sarcoma	0.000705	0.0147	CbGeAlD
Fluorouracil—UPP1—bone marrow—sarcoma	0.000698	0.0146	CbGeAlD
Fluorouracil—MTHFR—Folate-Alcohol and Cancer Pathway—CREB1—sarcoma	0.000683	0.0284	CbGpPWpGaD
Fluorouracil—DPYD—cardiac atrium—sarcoma	0.000672	0.014	CbGeAlD
Fluorouracil—DPYD—uterus—sarcoma	0.000668	0.014	CbGeAlD
Fluorouracil—TYMP—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000655	0.0272	CbGpPWpGaD
Fluorouracil—UMPS—testis—sarcoma	0.000651	0.0136	CbGeAlD
Fluorouracil—SLC29A1—mammary gland—sarcoma	0.000647	0.0135	CbGeAlD
Fluorouracil—UMPS—liver—sarcoma	0.000616	0.0129	CbGeAlD
Fluorouracil—UPP1—testis—sarcoma	0.000597	0.0125	CbGeAlD
Fluorouracil—TYMP—myometrium—sarcoma	0.000597	0.0125	CbGeAlD
Fluorouracil—SLC29A1—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000568	0.0236	CbGpPWpGaD
Fluorouracil—DPYD—bone marrow—sarcoma	0.000567	0.0118	CbGeAlD
Fluorouracil—UPP1—liver—sarcoma	0.000564	0.0118	CbGeAlD
Fluorouracil—ABCC4—Ectoderm Differentiation—PTPRB—sarcoma	0.000557	0.0231	CbGpPWpGaD
Fluorouracil—TYMP—seminal vesicle—sarcoma	0.000539	0.0113	CbGeAlD
Fluorouracil—TYMP—hematopoietic system—sarcoma	0.000513	0.0107	CbGeAlD
Fluorouracil—PPAT—tendon—sarcoma	0.000507	0.0106	CbGeAlD
Fluorouracil—ALB—mammary gland—sarcoma	0.000505	0.0105	CbGeAlD
Fluorouracil—TYMP—connective tissue—sarcoma	0.000494	0.0103	CbGeAlD
Fluorouracil—PPAT—bone marrow—sarcoma	0.000491	0.0103	CbGeAlD
Fluorouracil—DPYD—testis—sarcoma	0.000485	0.0101	CbGeAlD
Fluorouracil—MTHFR—hematopoietic system—sarcoma	0.000482	0.0101	CbGeAlD
Fluorouracil—UMPS—lymph node—sarcoma	0.000472	0.00986	CbGeAlD
Fluorouracil—SLC29A1—myometrium—sarcoma	0.000459	0.0096	CbGeAlD
Fluorouracil—DPYD—liver—sarcoma	0.000458	0.00958	CbGeAlD
Fluorouracil—TYMP—smooth muscle tissue—sarcoma	0.000451	0.00943	CbGeAlD
Fluorouracil—TYMS—hematopoietic system—sarcoma	0.00044	0.00919	CbGeAlD
Fluorouracil—UPP1—lymph node—sarcoma	0.000433	0.00904	CbGeAlD
Fluorouracil—MTHFR—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000432	0.0179	CbGpPWpGaD
Fluorouracil—TYMS—connective tissue—sarcoma	0.000423	0.00885	CbGeAlD
Fluorouracil—PPAT—testis—sarcoma	0.00042	0.00877	CbGeAlD
Fluorouracil—CYP2A6—seminal vesicle—sarcoma	0.000405	0.00847	CbGeAlD
Fluorouracil—PPAT—liver—sarcoma	0.000397	0.00829	CbGeAlD
Fluorouracil—SLC29A1—hematopoietic system—sarcoma	0.000394	0.00824	CbGeAlD
Fluorouracil—TYMP—cardiac atrium—sarcoma	0.000389	0.00813	CbGeAlD
Fluorouracil—MTHFR—Vitamin B12 Metabolism—HBA1—sarcoma	0.000388	0.0161	CbGpPWpGaD
Fluorouracil—TYMS—smooth muscle tissue—sarcoma	0.000387	0.00809	CbGeAlD
Fluorouracil—TYMP—uterus—sarcoma	0.000387	0.00809	CbGeAlD
Fluorouracil—TYMS—skin of body—sarcoma	0.000382	0.00799	CbGeAlD
Fluorouracil—SLC29A1—connective tissue—sarcoma	0.00038	0.00793	CbGeAlD
Fluorouracil—UMPS—Fluoropyrimidine Activity—TP53—sarcoma	0.000379	0.0157	CbGpPWpGaD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—sarcoma	0.000378	0.142	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Epirubicin—sarcoma	0.000378	0.142	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—sarcoma	0.000378	0.142	CbGdCrCtD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000376	0.0156	CbGpPWpGaD
Fluorouracil—TYMP—lymphoid tissue—sarcoma	0.000361	0.00754	CbGeAlD
Fluorouracil—ABCC3—hematopoietic system—sarcoma	0.000361	0.00754	CbGeAlD
Fluorouracil—CYP2C8—mammary gland—sarcoma	0.000355	0.00741	CbGeAlD
Fluorouracil—UPP1—Fluoropyrimidine Activity—TP53—sarcoma	0.000352	0.0146	CbGpPWpGaD
Fluorouracil—UPP2—Fluoropyrimidine Activity—TP53—sarcoma	0.000352	0.0146	CbGpPWpGaD
Fluorouracil—DPYD—lymph node—sarcoma	0.000351	0.00734	CbGeAlD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—sarcoma	0.000349	0.131	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—sarcoma	0.000349	0.131	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—sarcoma	0.000349	0.131	CbGdCrCtD
Fluorouracil—MTHFR—lymphoid tissue—sarcoma	0.000339	0.00709	CbGeAlD
Fluorouracil—TYMP—tendon—sarcoma	0.000339	0.00709	CbGeAlD
Fluorouracil—TYMS—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000335	0.0139	CbGpPWpGaD
Fluorouracil—TYMP—bone marrow—sarcoma	0.000329	0.00687	CbGeAlD
Fluorouracil—ABCC5—cardiac atrium—sarcoma	0.000326	0.00681	CbGeAlD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000323	0.0134	CbGpPWpGaD
Fluorouracil—TYMP—Bladder Cancer—MDM2—sarcoma	0.000318	0.0132	CbGpPWpGaD
Fluorouracil—ALB—Scavenging of heme from plasma—HBA1—sarcoma	0.000316	0.0131	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—HBA1—sarcoma	0.000316	0.0131	CbGpPWpGaD
Fluorouracil—CYP2C9—mammary gland—sarcoma	0.000315	0.00658	CbGeAlD
Fluorouracil—TYMS—lymphoid tissue—sarcoma	0.00031	0.00647	CbGeAlD
Fluorouracil—PPAT—lymph node—sarcoma	0.000304	0.00635	CbGeAlD
Fluorouracil—SLC29A1—cardiac atrium—sarcoma	0.000299	0.00626	CbGeAlD
Fluorouracil—SLC29A1—uterus—sarcoma	0.000298	0.00622	CbGeAlD
Fluorouracil—ABCC4—hematopoietic system—sarcoma	0.000298	0.00622	CbGeAlD
Fluorouracil—TYMS—tendon—sarcoma	0.000291	0.00608	CbGeAlD
Fluorouracil—ABCC5—tendon—sarcoma	0.000284	0.00594	CbGeAlD
Fluorouracil—TYMS—bone marrow—sarcoma	0.000282	0.00589	CbGeAlD
Fluorouracil—TYMP—testis—sarcoma	0.000281	0.00587	CbGeAlD
Fluorouracil—SLC22A7—testis—sarcoma	0.00028	0.00585	CbGeAlD
Fluorouracil—SLC29A1—lymphoid tissue—sarcoma	0.000278	0.0058	CbGeAlD
Fluorouracil—TYMP—Bladder Cancer—CCND1—sarcoma	0.000277	0.0115	CbGpPWpGaD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000277	0.0115	CbGpPWpGaD
Fluorouracil—ABCC5—bone marrow—sarcoma	0.000275	0.00575	CbGeAlD
Fluorouracil—TYMP—liver—sarcoma	0.000266	0.00555	CbGeAlD
Fluorouracil—SLC22A7—liver—sarcoma	0.000265	0.00553	CbGeAlD
Fluorouracil—MTHFR—testis—sarcoma	0.000264	0.00552	CbGeAlD
Fluorouracil—SLC29A1—tendon—sarcoma	0.000261	0.00545	CbGeAlD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000261	0.0108	CbGpPWpGaD
Fluorouracil—SLC29A1—bone marrow—sarcoma	0.000253	0.00528	CbGeAlD
Fluorouracil—MTHFR—Selenium Micronutrient Network—HBA1—sarcoma	0.000251	0.0104	CbGpPWpGaD
Fluorouracil—MTHFR—liver—sarcoma	0.00025	0.00522	CbGeAlD
Fluorouracil—ABCG2—myometrium—sarcoma	0.000245	0.00511	CbGeAlD
Fluorouracil—DPYD—Fluoropyrimidine Activity—TP53—sarcoma	0.000244	0.0101	CbGpPWpGaD
Fluorouracil—PPAT—Fluoropyrimidine Activity—TP53—sarcoma	0.000244	0.0101	CbGpPWpGaD
Fluorouracil—TYMP—Bladder Cancer—VEGFA—sarcoma	0.000242	0.01	CbGpPWpGaD
Fluorouracil—TYMS—testis—sarcoma	0.000241	0.00504	CbGeAlD
Fluorouracil—ABCC5—testis—sarcoma	0.000235	0.00492	CbGeAlD
Fluorouracil—ABCC4—Ectoderm Differentiation—PAX3—sarcoma	0.000231	0.00961	CbGpPWpGaD
Fluorouracil—TYMS—liver—sarcoma	0.000228	0.00476	CbGeAlD
Fluorouracil—ABCC4—uterus—sarcoma	0.000225	0.0047	CbGeAlD
Fluorouracil—ABCC5—liver—sarcoma	0.000223	0.00465	CbGeAlD
Fluorouracil—TYMP—Bladder Cancer—MYC—sarcoma	0.000222	0.00924	CbGpPWpGaD
Fluorouracil—ABCG2—seminal vesicle—sarcoma	0.000221	0.00462	CbGeAlD
Fluorouracil—ABCC3—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000219	0.0091	CbGpPWpGaD
Fluorouracil—TYMP—Bladder Cancer—EGFR—sarcoma	0.000218	0.00904	CbGpPWpGaD
Fluorouracil—CYP2C8—hematopoietic system—sarcoma	0.000216	0.00452	CbGeAlD
Fluorouracil—SLC29A1—testis—sarcoma	0.000216	0.00452	CbGeAlD
Fluorouracil—ABCG2—HIF-2-alpha transcription factor network—FLT1—sarcoma	0.000206	0.00857	CbGpPWpGaD
Fluorouracil—SLC29A1—liver—sarcoma	0.000204	0.00427	CbGeAlD
Fluorouracil—TYMP—lymph node—sarcoma	0.000204	0.00425	CbGeAlD
Fluorouracil—CYP1A2—hematopoietic system—sarcoma	0.000202	0.00423	CbGeAlD
Fluorouracil—CYP2A6—liver—sarcoma	0.0002	0.00417	CbGeAlD
Fluorouracil—ABCC3—testis—sarcoma	0.000198	0.00413	CbGeAlD
Fluorouracil—ABCC4—tendon—sarcoma	0.000197	0.00412	CbGeAlD
Fluorouracil—CYP2C9—hematopoietic system—sarcoma	0.000192	0.00401	CbGeAlD
Fluorouracil—MTHFR—lymph node—sarcoma	0.000191	0.004	CbGeAlD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000191	0.00793	CbGpPWpGaD
Fluorouracil—ABCC4—bone marrow—sarcoma	0.000191	0.00399	CbGeAlD
Fluorouracil—ABCC3—liver—sarcoma	0.000187	0.0039	CbGeAlD
Fluorouracil—TYMP—Bladder Cancer—TP53—sarcoma	0.000183	0.00759	CbGpPWpGaD
Fluorouracil—TYMS—Vinorelbine—Vincristine—sarcoma	0.000181	0.0679	CbGdCrCtD
Fluorouracil—TYMS—Podofilox—Etoposide—sarcoma	0.000181	0.0679	CbGdCrCtD
Fluorouracil—ABCC4—Platelet degranulation—VEGFC—sarcoma	0.000177	0.00737	CbGpPWpGaD
Fluorouracil—TYMP—Bladder Cancer—HRAS—sarcoma	0.000175	0.00726	CbGpPWpGaD
Fluorouracil—TYMS—lymph node—sarcoma	0.000175	0.00365	CbGeAlD
Fluorouracil—TYMP—Fluoropyrimidine Activity—TP53—sarcoma	0.000174	0.00722	CbGpPWpGaD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000174	0.00721	CbGpPWpGaD
Fluorouracil—ABCC5—lymph node—sarcoma	0.000171	0.00357	CbGeAlD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000169	0.00702	CbGpPWpGaD
Fluorouracil—ALB—testis—sarcoma	0.000169	0.00352	CbGeAlD
Fluorouracil—ABCC4—testis—sarcoma	0.000163	0.00341	CbGeAlD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000162	0.00674	CbGpPWpGaD
Fluorouracil—ALB—liver—sarcoma	0.000159	0.00333	CbGeAlD
Fluorouracil—ABCG2—uterus—sarcoma	0.000159	0.00332	CbGeAlD
Fluorouracil—SLC29A1—lymph node—sarcoma	0.000157	0.00327	CbGeAlD
Fluorouracil—ABCC4—liver—sarcoma	0.000154	0.00322	CbGeAlD
Fluorouracil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000154	0.00639	CbGpPWpGaD
Fluorouracil—SLC29A1—Fluoropyrimidine Activity—TP53—sarcoma	0.000151	0.00626	CbGpPWpGaD
Fluorouracil—ABCC3—lymph node—sarcoma	0.000143	0.00299	CbGeAlD
Fluorouracil—CYP2A6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000137	0.0057	CbGpPWpGaD
Fluorouracil—ABCG2—bone marrow—sarcoma	0.000135	0.00282	CbGeAlD
Fluorouracil—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HBA1—sarcoma	0.000126	0.00524	CbGpPWpGaD
Fluorouracil—TYMS—Vinblastine—Vincristine—sarcoma	0.000125	0.0467	CbGdCrCtD
Fluorouracil—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—sarcoma	0.000125	0.00517	CbGpPWpGaD
Fluorouracil—ALB—lymph node—sarcoma	0.000122	0.00255	CbGeAlD
Fluorouracil—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	0.000119	0.00494	CbGpPWpGaD
Fluorouracil—Paraesthesia—Thiotepa—sarcoma	0.000119	0.00138	CcSEcCtD
Fluorouracil—CYP2C8—testis—sarcoma	0.000118	0.00248	CbGeAlD
Fluorouracil—ABCC4—lymph node—sarcoma	0.000118	0.00247	CbGeAlD
Fluorouracil—Alopecia—Etoposide—sarcoma	0.000118	0.00137	CcSEcCtD
Fluorouracil—Discomfort—Mitoxantrone—sarcoma	0.000118	0.00137	CcSEcCtD
Fluorouracil—Somnolence—Thiotepa—sarcoma	0.000117	0.00136	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000117	0.00487	CbGpPWpGaD
Fluorouracil—Oedema—Vincristine—sarcoma	0.000117	0.00136	CcSEcCtD
Fluorouracil—Anaphylactic shock—Vincristine—sarcoma	0.000117	0.00136	CcSEcCtD
Fluorouracil—Infection—Vincristine—sarcoma	0.000116	0.00135	CcSEcCtD
Fluorouracil—Dyspepsia—Thiotepa—sarcoma	0.000116	0.00135	CcSEcCtD
Fluorouracil—Thrombophlebitis—Doxorubicin—sarcoma	0.000116	0.00134	CcSEcCtD
Fluorouracil—ABCG2—testis—sarcoma	0.000115	0.00241	CbGeAlD
Fluorouracil—Confusional state—Mitoxantrone—sarcoma	0.000115	0.00134	CcSEcCtD
Fluorouracil—Nervous system disorder—Vincristine—sarcoma	0.000115	0.00133	CcSEcCtD
Fluorouracil—Decreased appetite—Thiotepa—sarcoma	0.000115	0.00133	CcSEcCtD
Fluorouracil—Thrombocytopenia—Vincristine—sarcoma	0.000115	0.00133	CcSEcCtD
Fluorouracil—MTHFR—Fluoropyrimidine Activity—TP53—sarcoma	0.000115	0.00476	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000115	0.00476	CbGpPWpGaD
Fluorouracil—Oedema—Mitoxantrone—sarcoma	0.000114	0.00132	CcSEcCtD
Fluorouracil—Anaphylactic shock—Mitoxantrone—sarcoma	0.000114	0.00132	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Thiotepa—sarcoma	0.000114	0.00132	CcSEcCtD
Fluorouracil—Photosensitivity—Doxorubicin—sarcoma	0.000114	0.00132	CcSEcCtD
Fluorouracil—Decreased appetite—Dactinomycin—sarcoma	0.000114	0.00132	CcSEcCtD
Fluorouracil—Infection—Mitoxantrone—sarcoma	0.000113	0.00132	CcSEcCtD
Fluorouracil—Dermatitis bullous—Epirubicin—sarcoma	0.000113	0.00131	CcSEcCtD
Fluorouracil—Pain—Thiotepa—sarcoma	0.000113	0.00131	CcSEcCtD
Fluorouracil—Pain—Dactinomycin—sarcoma	0.000112	0.0013	CcSEcCtD
Fluorouracil—CYP2C8—liver—sarcoma	0.000112	0.00234	CbGeAlD
Fluorouracil—Thrombocytopenia—Mitoxantrone—sarcoma	0.000112	0.0013	CcSEcCtD
Fluorouracil—Anorexia—Vincristine—sarcoma	0.000112	0.0013	CcSEcCtD
Fluorouracil—Tachycardia—Mitoxantrone—sarcoma	0.000111	0.00129	CcSEcCtD
Fluorouracil—Cardiac failure—Epirubicin—sarcoma	0.000111	0.00129	CcSEcCtD
Fluorouracil—Lethargy—Epirubicin—sarcoma	0.00011	0.00128	CcSEcCtD
Fluorouracil—Hypotension—Vincristine—sarcoma	0.000109	0.00127	CcSEcCtD
Fluorouracil—Feeling abnormal—Thiotepa—sarcoma	0.000109	0.00126	CcSEcCtD
Fluorouracil—ABCG2—liver—sarcoma	0.000109	0.00228	CbGeAlD
Fluorouracil—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—sarcoma	0.000109	0.00452	CbGpPWpGaD
Fluorouracil—Anorexia—Mitoxantrone—sarcoma	0.000109	0.00126	CcSEcCtD
Fluorouracil—Osteoarthritis—Epirubicin—sarcoma	0.000108	0.00126	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000108	0.00126	CcSEcCtD
Fluorouracil—Feeling abnormal—Dactinomycin—sarcoma	0.000108	0.00125	CcSEcCtD
Fluorouracil—Anaemia—Etoposide—sarcoma	0.000108	0.00125	CcSEcCtD
Fluorouracil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000107	0.00445	CbGpPWpGaD
Fluorouracil—Musculoskeletal discomfort—Vincristine—sarcoma	0.000107	0.00124	CcSEcCtD
Fluorouracil—Hypotension—Mitoxantrone—sarcoma	0.000107	0.00124	CcSEcCtD
Fluorouracil—Insomnia—Vincristine—sarcoma	0.000106	0.00123	CcSEcCtD
Fluorouracil—ALB—Vitamin B12 Metabolism—HBA1—sarcoma	0.000106	0.0044	CbGpPWpGaD
Fluorouracil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000106	0.00438	CbGpPWpGaD
Fluorouracil—Paraesthesia—Vincristine—sarcoma	0.000105	0.00122	CcSEcCtD
Fluorouracil—Urticaria—Thiotepa—sarcoma	0.000105	0.00122	CcSEcCtD
Fluorouracil—Dermatitis bullous—Doxorubicin—sarcoma	0.000105	0.00122	CcSEcCtD
Fluorouracil—CYP1A2—liver—sarcoma	0.000105	0.00219	CbGeAlD
Fluorouracil—Body temperature increased—Thiotepa—sarcoma	0.000104	0.00121	CcSEcCtD
Fluorouracil—Leukopenia—Etoposide—sarcoma	0.000104	0.00121	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000104	0.00121	CcSEcCtD
Fluorouracil—Body temperature increased—Dactinomycin—sarcoma	0.000104	0.0012	CcSEcCtD
Fluorouracil—Cardiac arrest—Epirubicin—sarcoma	0.000103	0.00119	CcSEcCtD
Fluorouracil—Cardiac failure—Doxorubicin—sarcoma	0.000103	0.00119	CcSEcCtD
Fluorouracil—MTHFR—Folate Metabolism—IL2—sarcoma	0.000103	0.00426	CbGpPWpGaD
Fluorouracil—Paraesthesia—Mitoxantrone—sarcoma	0.000102	0.00119	CcSEcCtD
Fluorouracil—Lethargy—Doxorubicin—sarcoma	0.000102	0.00119	CcSEcCtD
Fluorouracil—Decreased appetite—Vincristine—sarcoma	0.000102	0.00118	CcSEcCtD
Fluorouracil—Ataxia—Epirubicin—sarcoma	0.000102	0.00118	CcSEcCtD
Fluorouracil—Dyspnoea—Mitoxantrone—sarcoma	0.000102	0.00118	CcSEcCtD
Fluorouracil—Somnolence—Mitoxantrone—sarcoma	0.000101	0.00118	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Vincristine—sarcoma	0.000101	0.00117	CcSEcCtD
Fluorouracil—Convulsion—Etoposide—sarcoma	0.000101	0.00117	CcSEcCtD
Fluorouracil—Dyspepsia—Mitoxantrone—sarcoma	0.0001	0.00117	CcSEcCtD
Fluorouracil—Pain—Vincristine—sarcoma	0.0001	0.00116	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.0001	0.00116	CcSEcCtD
Fluorouracil—Osteoarthritis—Doxorubicin—sarcoma	0.0001	0.00116	CcSEcCtD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—TP53—sarcoma	9.98e-05	0.00414	CbGpPWpGaD
Fluorouracil—CYP2C9—liver—sarcoma	9.95e-05	0.00208	CbGeAlD
Fluorouracil—Dry skin—Epirubicin—sarcoma	9.92e-05	0.00115	CcSEcCtD
Fluorouracil—Decreased appetite—Mitoxantrone—sarcoma	9.92e-05	0.00115	CcSEcCtD
Fluorouracil—Chest pain—Etoposide—sarcoma	9.9e-05	0.00115	CcSEcCtD
Fluorouracil—Discomfort—Etoposide—sarcoma	9.78e-05	0.00114	CcSEcCtD
Fluorouracil—Pain—Mitoxantrone—sarcoma	9.76e-05	0.00113	CcSEcCtD
Fluorouracil—Hypersensitivity—Thiotepa—sarcoma	9.74e-05	0.00113	CcSEcCtD
Fluorouracil—Nasopharyngitis—Epirubicin—sarcoma	9.68e-05	0.00112	CcSEcCtD
Fluorouracil—Hypersensitivity—Dactinomycin—sarcoma	9.66e-05	0.00112	CcSEcCtD
Fluorouracil—Confusional state—Etoposide—sarcoma	9.57e-05	0.00111	CcSEcCtD
Fluorouracil—Muscular weakness—Epirubicin—sarcoma	9.55e-05	0.00111	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—sarcoma	9.53e-05	0.00111	CcSEcCtD
Fluorouracil—Anaphylactic shock—Etoposide—sarcoma	9.49e-05	0.0011	CcSEcCtD
Fluorouracil—Infection—Etoposide—sarcoma	9.43e-05	0.00109	CcSEcCtD
Fluorouracil—Ataxia—Doxorubicin—sarcoma	9.42e-05	0.00109	CcSEcCtD
Fluorouracil—Feeling abnormal—Mitoxantrone—sarcoma	9.4e-05	0.00109	CcSEcCtD
Fluorouracil—Dysphagia—Epirubicin—sarcoma	9.36e-05	0.00109	CcSEcCtD
Fluorouracil—Pruritus—Thiotepa—sarcoma	9.35e-05	0.00109	CcSEcCtD
Fluorouracil—Thrombocytopenia—Etoposide—sarcoma	9.29e-05	0.00108	CcSEcCtD
Fluorouracil—ABCC5—Carbohydrate metabolism—ENO2—sarcoma	9.26e-05	0.00385	CbGpPWpGaD
Fluorouracil—Tachycardia—Etoposide—sarcoma	9.26e-05	0.00108	CcSEcCtD
Fluorouracil—Eosinophilia—Epirubicin—sarcoma	9.26e-05	0.00108	CcSEcCtD
Fluorouracil—Body temperature increased—Vincristine—sarcoma	9.26e-05	0.00108	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—sarcoma	9.18e-05	0.00107	CcSEcCtD
Fluorouracil—Angina pectoris—Epirubicin—sarcoma	9.11e-05	0.00106	CcSEcCtD
Fluorouracil—Urticaria—Mitoxantrone—sarcoma	9.07e-05	0.00105	CcSEcCtD
Fluorouracil—Anorexia—Etoposide—sarcoma	9.05e-05	0.00105	CcSEcCtD
Fluorouracil—Diarrhoea—Thiotepa—sarcoma	9.04e-05	0.00105	CcSEcCtD
Fluorouracil—Body temperature increased—Mitoxantrone—sarcoma	9.02e-05	0.00105	CcSEcCtD
Fluorouracil—Diarrhoea—Dactinomycin—sarcoma	8.97e-05	0.00104	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—sarcoma	8.96e-05	0.00104	CcSEcCtD
Fluorouracil—TYMS—Fluoropyrimidine Activity—TP53—sarcoma	8.89e-05	0.00369	CbGpPWpGaD
Fluorouracil—Pancytopenia—Epirubicin—sarcoma	8.89e-05	0.00103	CcSEcCtD
Fluorouracil—Hypotension—Etoposide—sarcoma	8.87e-05	0.00103	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—sarcoma	8.83e-05	0.00103	CcSEcCtD
Fluorouracil—Dizziness—Thiotepa—sarcoma	8.74e-05	0.00101	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Epirubicin—sarcoma	8.7e-05	0.00101	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—sarcoma	8.66e-05	0.001	CcSEcCtD
Fluorouracil—Hypersensitivity—Vincristine—sarcoma	8.63e-05	0.001	CcSEcCtD
Fluorouracil—ALB—Folate Metabolism—HBA1—sarcoma	8.62e-05	0.00358	CbGpPWpGaD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—TP53—sarcoma	8.59e-05	0.00357	CbGpPWpGaD
Fluorouracil—Eosinophilia—Doxorubicin—sarcoma	8.57e-05	0.000995	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Epirubicin—sarcoma	8.54e-05	0.000991	CcSEcCtD
Fluorouracil—Paraesthesia—Etoposide—sarcoma	8.52e-05	0.000989	CcSEcCtD
Fluorouracil—Dyspnoea—Etoposide—sarcoma	8.46e-05	0.000982	CcSEcCtD
Fluorouracil—Somnolence—Etoposide—sarcoma	8.44e-05	0.00098	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—sarcoma	8.43e-05	0.000979	CcSEcCtD
Fluorouracil—Hypersensitivity—Mitoxantrone—sarcoma	8.41e-05	0.000976	CcSEcCtD
Fluorouracil—Vomiting—Thiotepa—sarcoma	8.4e-05	0.000975	CcSEcCtD
Fluorouracil—Pneumonia—Epirubicin—sarcoma	8.39e-05	0.000974	CcSEcCtD
Fluorouracil—ABCG2—lymph node—sarcoma	8.35e-05	0.00174	CbGeAlD
Fluorouracil—Infestation—Epirubicin—sarcoma	8.34e-05	0.000968	CcSEcCtD
Fluorouracil—Infestation NOS—Epirubicin—sarcoma	8.34e-05	0.000968	CcSEcCtD
Fluorouracil—Vomiting—Dactinomycin—sarcoma	8.34e-05	0.000968	CcSEcCtD
Fluorouracil—UMPS—Metabolism—ENO2—sarcoma	8.34e-05	0.00346	CbGpPWpGaD
Fluorouracil—Rash—Thiotepa—sarcoma	8.33e-05	0.000967	CcSEcCtD
Fluorouracil—Dermatitis—Thiotepa—sarcoma	8.32e-05	0.000966	CcSEcCtD
Fluorouracil—UMPS—Metabolism—HBA1—sarcoma	8.28e-05	0.00344	CbGpPWpGaD
Fluorouracil—Headache—Thiotepa—sarcoma	8.28e-05	0.000961	CcSEcCtD
Fluorouracil—Rash—Dactinomycin—sarcoma	8.27e-05	0.00096	CcSEcCtD
Fluorouracil—Decreased appetite—Etoposide—sarcoma	8.25e-05	0.000958	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—sarcoma	8.22e-05	0.000954	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Etoposide—sarcoma	8.2e-05	0.000951	CcSEcCtD
Fluorouracil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	8.18e-05	0.0034	CbGpPWpGaD
Fluorouracil—Neuropathy peripheral—Epirubicin—sarcoma	8.18e-05	0.000949	CcSEcCtD
Fluorouracil—Stomatitis—Epirubicin—sarcoma	8.13e-05	0.000944	CcSEcCtD
Fluorouracil—Pain—Etoposide—sarcoma	8.12e-05	0.000942	CcSEcCtD
Fluorouracil—Conjunctivitis—Epirubicin—sarcoma	8.11e-05	0.000941	CcSEcCtD
Fluorouracil—Urinary tract infection—Epirubicin—sarcoma	8.11e-05	0.000941	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—sarcoma	8.05e-05	0.000934	CcSEcCtD
Fluorouracil—ALB—Platelet degranulation—VEGFC—sarcoma	8.03e-05	0.00333	CbGpPWpGaD
Fluorouracil—Diarrhoea—Vincristine—sarcoma	8.02e-05	0.000931	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—sarcoma	7.9e-05	0.000917	CcSEcCtD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—VEGFC—sarcoma	7.87e-05	0.00327	CbGpPWpGaD
Fluorouracil—Epistaxis—Epirubicin—sarcoma	7.87e-05	0.000913	CcSEcCtD
Fluorouracil—Nausea—Thiotepa—sarcoma	7.85e-05	0.000911	CcSEcCtD
Fluorouracil—Sinusitis—Epirubicin—sarcoma	7.83e-05	0.000909	CcSEcCtD
Fluorouracil—Feeling abnormal—Etoposide—sarcoma	7.82e-05	0.000908	CcSEcCtD
Fluorouracil—Diarrhoea—Mitoxantrone—sarcoma	7.81e-05	0.000906	CcSEcCtD
Fluorouracil—Nausea—Dactinomycin—sarcoma	7.79e-05	0.000904	CcSEcCtD
Fluorouracil—Agranulocytosis—Epirubicin—sarcoma	7.79e-05	0.000904	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—sarcoma	7.76e-05	0.000901	CcSEcCtD
Fluorouracil—UPP2—Metabolism—ENO2—sarcoma	7.75e-05	0.00322	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—ENO2—sarcoma	7.75e-05	0.00322	CbGpPWpGaD
Fluorouracil—Dizziness—Vincristine—sarcoma	7.75e-05	0.000899	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—sarcoma	7.72e-05	0.000896	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—sarcoma	7.72e-05	0.000896	CcSEcCtD
Fluorouracil—UPP1—Metabolism—HBA1—sarcoma	7.7e-05	0.0032	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—HBA1—sarcoma	7.7e-05	0.0032	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	7.65e-05	0.00318	CbGpPWpGaD
Fluorouracil—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	7.63e-05	0.00317	CbGpPWpGaD
Fluorouracil—Neuropathy peripheral—Doxorubicin—sarcoma	7.57e-05	0.000878	CcSEcCtD
Fluorouracil—Urticaria—Etoposide—sarcoma	7.54e-05	0.000875	CcSEcCtD
Fluorouracil—Haemoglobin—Epirubicin—sarcoma	7.53e-05	0.000874	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—sarcoma	7.52e-05	0.000873	CcSEcCtD
Fluorouracil—Rhinitis—Epirubicin—sarcoma	7.51e-05	0.000872	CcSEcCtD
Fluorouracil—Body temperature increased—Etoposide—sarcoma	7.5e-05	0.000871	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—sarcoma	7.5e-05	0.000871	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—sarcoma	7.5e-05	0.000871	CcSEcCtD
Fluorouracil—Haemorrhage—Epirubicin—sarcoma	7.49e-05	0.000869	CcSEcCtD
Fluorouracil—Hypoaesthesia—Epirubicin—sarcoma	7.45e-05	0.000865	CcSEcCtD
Fluorouracil—Vomiting—Vincristine—sarcoma	7.45e-05	0.000865	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—sarcoma	7.43e-05	0.000863	CcSEcCtD
Fluorouracil—Rash—Vincristine—sarcoma	7.39e-05	0.000858	CcSEcCtD
Fluorouracil—Dermatitis—Vincristine—sarcoma	7.38e-05	0.000857	CcSEcCtD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—TP53—sarcoma	7.36e-05	0.00306	CbGpPWpGaD
Fluorouracil—Headache—Vincristine—sarcoma	7.34e-05	0.000852	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—sarcoma	7.28e-05	0.000845	CcSEcCtD
Fluorouracil—Vomiting—Mitoxantrone—sarcoma	7.26e-05	0.000842	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—sarcoma	7.24e-05	0.000841	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—sarcoma	7.2e-05	0.000836	CcSEcCtD
Fluorouracil—Rash—Mitoxantrone—sarcoma	7.2e-05	0.000835	CcSEcCtD
Fluorouracil—Dermatitis—Mitoxantrone—sarcoma	7.19e-05	0.000834	CcSEcCtD
Fluorouracil—Headache—Mitoxantrone—sarcoma	7.15e-05	0.00083	CcSEcCtD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	7.14e-05	0.00296	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—PLCG1—sarcoma	7.07e-05	0.00294	CbGpPWpGaD
Fluorouracil—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	7.05e-05	0.00293	CbGpPWpGaD
Fluorouracil—Hypersensitivity—Etoposide—sarcoma	6.99e-05	0.000812	CcSEcCtD
Fluorouracil—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	6.99e-05	0.0029	CbGpPWpGaD
Fluorouracil—Haemoglobin—Doxorubicin—sarcoma	6.97e-05	0.000808	CcSEcCtD
Fluorouracil—Nausea—Vincristine—sarcoma	6.96e-05	0.000808	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—sarcoma	6.95e-05	0.000806	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—sarcoma	6.93e-05	0.000804	CcSEcCtD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—TP53—sarcoma	6.92e-05	0.00287	CbGpPWpGaD
Fluorouracil—Hypoaesthesia—Doxorubicin—sarcoma	6.9e-05	0.0008	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—sarcoma	6.88e-05	0.000798	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle, Mitotic—STAG1—sarcoma	6.86e-05	0.00285	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—HBA1—sarcoma	6.85e-05	0.00284	CbGpPWpGaD
Fluorouracil—Nausea—Mitoxantrone—sarcoma	6.78e-05	0.000787	CcSEcCtD
Fluorouracil—Pruritus—Etoposide—sarcoma	6.72e-05	0.00078	CcSEcCtD
Fluorouracil—Arrhythmia—Epirubicin—sarcoma	6.69e-05	0.000777	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—sarcoma	6.62e-05	0.000768	CcSEcCtD
Fluorouracil—MTHFR—Folate Metabolism—TP53—sarcoma	6.59e-05	0.00273	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PLCG1—sarcoma	6.58e-05	0.00273	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PLCG1—sarcoma	6.58e-05	0.00273	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	6.56e-05	0.00272	CbGpPWpGaD
Fluorouracil—Erythema—Epirubicin—sarcoma	6.52e-05	0.000757	CcSEcCtD
Fluorouracil—Diarrhoea—Etoposide—sarcoma	6.49e-05	0.000754	CcSEcCtD
Fluorouracil—Dizziness—Etoposide—sarcoma	6.28e-05	0.000729	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	6.23e-05	0.00259	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	6.22e-05	0.00258	CbGpPWpGaD
Fluorouracil—Arrhythmia—Doxorubicin—sarcoma	6.19e-05	0.000719	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—sarcoma	6.14e-05	0.000713	CcSEcCtD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	6.14e-05	0.00255	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—STAG1—sarcoma	6.13e-05	0.00255	CbGpPWpGaD
Fluorouracil—Alopecia—Doxorubicin—sarcoma	6.12e-05	0.000711	CcSEcCtD
Fluorouracil—Vomiting—Etoposide—sarcoma	6.04e-05	0.000701	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—sarcoma	6.03e-05	0.0007	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—sarcoma	6.03e-05	0.000699	CcSEcCtD
Fluorouracil—Rash—Etoposide—sarcoma	5.99e-05	0.000695	CcSEcCtD
Fluorouracil—Dermatitis—Etoposide—sarcoma	5.98e-05	0.000694	CcSEcCtD
Fluorouracil—Headache—Etoposide—sarcoma	5.95e-05	0.00069	CcSEcCtD
Fluorouracil—Leukopenia—Epirubicin—sarcoma	5.84e-05	0.000677	CcSEcCtD
Fluorouracil—TYMS—E2F transcription factor network—MYC—sarcoma	5.74e-05	0.00238	CbGpPWpGaD
Fluorouracil—Vision blurred—Doxorubicin—sarcoma	5.69e-05	0.00066	CcSEcCtD
Fluorouracil—Convulsion—Epirubicin—sarcoma	5.65e-05	0.000656	CcSEcCtD
Fluorouracil—Nausea—Etoposide—sarcoma	5.64e-05	0.000654	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—sarcoma	5.58e-05	0.000647	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—sarcoma	5.55e-05	0.000644	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—sarcoma	5.55e-05	0.000644	CcSEcCtD
Fluorouracil—ABCC4—Hemostasis—TEK—sarcoma	5.53e-05	0.0023	CbGpPWpGaD
Fluorouracil—Discomfort—Epirubicin—sarcoma	5.48e-05	0.000637	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—sarcoma	5.4e-05	0.000627	CcSEcCtD
Fluorouracil—PPAT—Metabolism—ENO2—sarcoma	5.37e-05	0.00223	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—ENO2—sarcoma	5.37e-05	0.00223	CbGpPWpGaD
Fluorouracil—Confusional state—Epirubicin—sarcoma	5.37e-05	0.000623	CcSEcCtD
Fluorouracil—DPYD—Metabolism—HBA1—sarcoma	5.34e-05	0.00222	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—HBA1—sarcoma	5.34e-05	0.00222	CbGpPWpGaD
Fluorouracil—Anaphylactic shock—Epirubicin—sarcoma	5.32e-05	0.000618	CcSEcCtD
Fluorouracil—Oedema—Epirubicin—sarcoma	5.32e-05	0.000618	CcSEcCtD
Fluorouracil—Infection—Epirubicin—sarcoma	5.29e-05	0.000614	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle—NPM1—sarcoma	5.26e-05	0.00218	CbGpPWpGaD
Fluorouracil—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	5.24e-05	0.00218	CbGpPWpGaD
Fluorouracil—Convulsion—Doxorubicin—sarcoma	5.23e-05	0.000607	CcSEcCtD
Fluorouracil—Nervous system disorder—Epirubicin—sarcoma	5.22e-05	0.000606	CcSEcCtD
Fluorouracil—Thrombocytopenia—Epirubicin—sarcoma	5.21e-05	0.000605	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—sarcoma	5.19e-05	0.000603	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—sarcoma	5.14e-05	0.000596	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—sarcoma	5.14e-05	0.000596	CcSEcCtD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	5.07e-05	0.00211	CbGpPWpGaD
Fluorouracil—Discomfort—Doxorubicin—sarcoma	5.07e-05	0.000589	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—sarcoma	5.07e-05	0.000589	CcSEcCtD
Fluorouracil—ABCC4—Hemostasis—ANGPT2—sarcoma	5.06e-05	0.0021	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—MYC—sarcoma	4.99e-05	0.00207	CbGpPWpGaD
Fluorouracil—Hypotension—Epirubicin—sarcoma	4.97e-05	0.000577	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—sarcoma	4.96e-05	0.000576	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—sarcoma	4.92e-05	0.000571	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—sarcoma	4.92e-05	0.000571	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—sarcoma	4.89e-05	0.000568	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—sarcoma	4.85e-05	0.000563	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—sarcoma	4.83e-05	0.00056	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—sarcoma	4.82e-05	0.00056	CcSEcCtD
Fluorouracil—Insomnia—Epirubicin—sarcoma	4.81e-05	0.000559	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—sarcoma	4.81e-05	0.000558	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—sarcoma	4.78e-05	0.000555	CcSEcCtD
Fluorouracil—Dyspnoea—Epirubicin—sarcoma	4.74e-05	0.000551	CcSEcCtD
Fluorouracil—Somnolence—Epirubicin—sarcoma	4.73e-05	0.000549	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—sarcoma	4.69e-05	0.000545	CcSEcCtD
Fluorouracil—Dyspepsia—Epirubicin—sarcoma	4.68e-05	0.000544	CcSEcCtD
Fluorouracil—Decreased appetite—Epirubicin—sarcoma	4.63e-05	0.000537	CcSEcCtD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—TP53—sarcoma	4.61e-05	0.00191	CbGpPWpGaD
Fluorouracil—Hypotension—Doxorubicin—sarcoma	4.6e-05	0.000534	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	4.6e-05	0.00191	CbGpPWpGaD
Fluorouracil—Gastrointestinal disorder—Epirubicin—sarcoma	4.59e-05	0.000533	CcSEcCtD
Fluorouracil—DPYD—Metabolism—PLCG1—sarcoma	4.56e-05	0.00189	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PLCG1—sarcoma	4.56e-05	0.00189	CbGpPWpGaD
Fluorouracil—Pain—Epirubicin—sarcoma	4.55e-05	0.000528	CcSEcCtD
Fluorouracil—ABCC4—Platelet degranulation—VEGFA—sarcoma	4.51e-05	0.00187	CbGpPWpGaD
Fluorouracil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	4.5e-05	0.00187	CbGpPWpGaD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—sarcoma	4.49e-05	0.000521	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—sarcoma	4.45e-05	0.000517	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—sarcoma	4.42e-05	0.000513	CcSEcCtD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	4.42e-05	0.00183	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—CREB1—sarcoma	4.41e-05	0.00183	CbGpPWpGaD
Fluorouracil—Dyspnoea—Doxorubicin—sarcoma	4.39e-05	0.000509	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—sarcoma	4.38e-05	0.000509	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—sarcoma	4.38e-05	0.000508	CcSEcCtD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—CCND1—sarcoma	4.37e-05	0.00182	CbGpPWpGaD
Fluorouracil—Dyspepsia—Doxorubicin—sarcoma	4.33e-05	0.000503	CcSEcCtD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	4.3e-05	0.00178	CbGpPWpGaD
Fluorouracil—Decreased appetite—Doxorubicin—sarcoma	4.28e-05	0.000497	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—sarcoma	4.25e-05	0.000493	CcSEcCtD
Fluorouracil—Urticaria—Epirubicin—sarcoma	4.23e-05	0.000491	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—sarcoma	4.21e-05	0.000489	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—sarcoma	4.21e-05	0.000488	CcSEcCtD
Fluorouracil—TYMS—G1/S Transition—MYC—sarcoma	4.16e-05	0.00173	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—TP53—sarcoma	4.09e-05	0.0017	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFC—sarcoma	4.06e-05	0.00168	CbGpPWpGaD
Fluorouracil—Feeling abnormal—Doxorubicin—sarcoma	4.06e-05	0.000471	CcSEcCtD
Fluorouracil—Hypersensitivity—Epirubicin—sarcoma	3.92e-05	0.000455	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—sarcoma	3.91e-05	0.000454	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—sarcoma	3.89e-05	0.000452	CcSEcCtD
Fluorouracil—MTHFR—Disease—TLE1—sarcoma	3.86e-05	0.0016	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	3.86e-05	0.0016	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ENO2—sarcoma	3.83e-05	0.00159	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	3.8e-05	0.00158	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—HBA1—sarcoma	3.8e-05	0.00158	CbGpPWpGaD
Fluorouracil—Pruritus—Epirubicin—sarcoma	3.76e-05	0.000437	CcSEcCtD
Fluorouracil—Diarrhoea—Epirubicin—sarcoma	3.64e-05	0.000423	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—sarcoma	3.63e-05	0.000421	CcSEcCtD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	3.56e-05	0.00148	CbGpPWpGaD
Fluorouracil—Dizziness—Epirubicin—sarcoma	3.52e-05	0.000408	CcSEcCtD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—MYC—sarcoma	3.51e-05	0.00146	CbGpPWpGaD
Fluorouracil—Pruritus—Doxorubicin—sarcoma	3.48e-05	0.000404	CcSEcCtD
Fluorouracil—MTHFR—Disease—NPM1—sarcoma	3.48e-05	0.00145	CbGpPWpGaD
Fluorouracil—Vomiting—Epirubicin—sarcoma	3.38e-05	0.000393	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—sarcoma	3.37e-05	0.000391	CcSEcCtD
Fluorouracil—ABCC5—Disease—TLE1—sarcoma	3.36e-05	0.00139	CbGpPWpGaD
Fluorouracil—Rash—Epirubicin—sarcoma	3.35e-05	0.000389	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—sarcoma	3.35e-05	0.000389	CcSEcCtD
Fluorouracil—Headache—Epirubicin—sarcoma	3.33e-05	0.000387	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	3.31e-05	0.00138	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—CTNNB1—sarcoma	3.31e-05	0.00137	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	3.31e-05	0.00137	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	3.28e-05	0.00136	CbGpPWpGaD
Fluorouracil—Dizziness—Doxorubicin—sarcoma	3.26e-05	0.000378	CcSEcCtD
Fluorouracil—TYMP—Metabolism—PLCG1—sarcoma	3.25e-05	0.00135	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PLCG1—sarcoma	3.19e-05	0.00132	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—JUN—sarcoma	3.17e-05	0.00132	CbGpPWpGaD
Fluorouracil—Nausea—Epirubicin—sarcoma	3.16e-05	0.000367	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—sarcoma	3.13e-05	0.000363	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—sarcoma	3.1e-05	0.00036	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—sarcoma	3.1e-05	0.00036	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—sarcoma	3.08e-05	0.000358	CcSEcCtD
Fluorouracil—ABCC5—Disease—NPM1—sarcoma	3.03e-05	0.00126	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ENO2—sarcoma	3.02e-05	0.00125	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	2.97e-05	0.00123	CbGpPWpGaD
Fluorouracil—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	2.93e-05	0.00121	CbGpPWpGaD
Fluorouracil—Nausea—Doxorubicin—sarcoma	2.92e-05	0.000339	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	2.89e-05	0.0012	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IL2—sarcoma	2.8e-05	0.00116	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—MYC—sarcoma	2.68e-05	0.00111	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	2.66e-05	0.0011	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ENO2—sarcoma	2.62e-05	0.00109	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	2.61e-05	0.00109	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	2.6e-05	0.00108	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PLCG1—sarcoma	2.56e-05	0.00106	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	2.54e-05	0.00106	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ENO2—sarcoma	2.53e-05	0.00105	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—HBA1—sarcoma	2.51e-05	0.00104	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TEK—sarcoma	2.5e-05	0.00104	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CXCR4—sarcoma	2.46e-05	0.00102	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.46e-05	0.00102	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—IL2—sarcoma	2.35e-05	0.000977	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—ANGPT2—sarcoma	2.29e-05	0.00095	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	2.28e-05	0.000947	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	2.28e-05	0.000947	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PLCG1—sarcoma	2.23e-05	0.000925	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	2.22e-05	0.000923	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ENO2—sarcoma	2.2e-05	0.000913	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	2.19e-05	0.000911	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—HBA1—sarcoma	2.18e-05	0.000907	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.18e-05	0.000906	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PLCG1—sarcoma	2.14e-05	0.00089	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CXCR4—sarcoma	2.14e-05	0.000888	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—sarcoma	2.1e-05	0.00087	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—SRC—sarcoma	2.05e-05	0.000853	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	2.04e-05	0.000849	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—VEGFA—sarcoma	2.04e-05	0.000847	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—sarcoma	2e-05	0.00083	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	2e-05	0.00083	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	2e-05	0.00083	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ENO2—sarcoma	1.96e-05	0.000813	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—HBA1—sarcoma	1.95e-05	0.000808	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	1.94e-05	0.000807	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	1.89e-05	0.000784	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PLCG1—sarcoma	1.87e-05	0.000774	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFC—sarcoma	1.84e-05	0.000762	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—FOXO1—sarcoma	1.82e-05	0.000754	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PDGFRB—sarcoma	1.81e-05	0.000752	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—sarcoma	1.8e-05	0.000747	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PDGFRA—sarcoma	1.78e-05	0.000741	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PLCG1—sarcoma	1.66e-05	0.00069	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MDM2—sarcoma	1.65e-05	0.000684	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ENO2—sarcoma	1.62e-05	0.000673	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—HBA1—sarcoma	1.61e-05	0.000669	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	1.61e-05	0.000667	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CCND1—sarcoma	1.6e-05	0.000666	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—FOXO1—sarcoma	1.58e-05	0.000656	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PDGFRB—sarcoma	1.58e-05	0.000655	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PDGFRA—sarcoma	1.55e-05	0.000645	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PLCG1—sarcoma	1.44e-05	0.000599	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CCND1—sarcoma	1.43e-05	0.000595	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KIT—sarcoma	1.38e-05	0.000574	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PLCG1—sarcoma	1.38e-05	0.000571	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CREB1—sarcoma	1.32e-05	0.000547	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—MYC—sarcoma	1.29e-05	0.000534	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IL2—sarcoma	1.21e-05	0.000504	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KIT—sarcoma	1.2e-05	0.0005	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYC—sarcoma	1.15e-05	0.000478	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CREB1—sarcoma	1.15e-05	0.000476	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ENO2—sarcoma	1.12e-05	0.000464	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—HBA1—sarcoma	1.11e-05	0.000461	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MDM2—sarcoma	1.09e-05	0.000452	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	1.07e-05	0.000442	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—SRC—sarcoma	1.06e-05	0.00044	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—sarcoma	1.03e-05	0.000428	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NRAS—sarcoma	1.02e-05	0.000423	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ENO2—sarcoma	1.02e-05	0.000421	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—HBA1—sarcoma	1.01e-05	0.000419	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MDM2—sarcoma	9.48e-06	0.000394	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PLCG1—sarcoma	9.48e-06	0.000394	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—sarcoma	9.45e-06	0.000392	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CTNNB1—sarcoma	9.4e-06	0.00039	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	9.29e-06	0.000386	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	9.05e-06	0.000376	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—sarcoma	8.77e-06	0.000364	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PLCG1—sarcoma	8.61e-06	0.000358	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SRC—sarcoma	8.49e-06	0.000353	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CTNNB1—sarcoma	8.18e-06	0.00034	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NRAS—sarcoma	8.17e-06	0.000339	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—sarcoma	7.79e-06	0.000323	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—sarcoma	7.61e-06	0.000316	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—sarcoma	7.45e-06	0.000309	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EGFR—sarcoma	7.44e-06	0.000309	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SRC—sarcoma	7.39e-06	0.000307	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRAS—sarcoma	7.11e-06	0.000295	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—sarcoma	7.03e-06	0.000292	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ENO2—sarcoma	6.93e-06	0.000288	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ENO2—sarcoma	6.89e-06	0.000286	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HBA1—sarcoma	6.89e-06	0.000286	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HBA1—sarcoma	6.85e-06	0.000284	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—sarcoma	6.63e-06	0.000275	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGFR—sarcoma	6.48e-06	0.000269	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—sarcoma	6.12e-06	0.000254	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—sarcoma	5.98e-06	0.000248	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PLCG1—sarcoma	5.88e-06	0.000244	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PLCG1—sarcoma	5.85e-06	0.000243	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ENO2—sarcoma	5.64e-06	0.000234	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HBA1—sarcoma	5.61e-06	0.000233	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—sarcoma	5.49e-06	0.000228	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—sarcoma	5.2e-06	0.000216	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ENO2—sarcoma	4.82e-06	0.0002	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HBA1—sarcoma	4.79e-06	0.000199	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SRC—sarcoma	4.79e-06	0.000199	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PLCG1—sarcoma	4.79e-06	0.000199	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—sarcoma	4.67e-06	0.000194	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—sarcoma	4.61e-06	0.000191	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PLCG1—sarcoma	4.09e-06	0.00017	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—sarcoma	3.97e-06	0.000165	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—sarcoma	3.53e-06	0.000146	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—sarcoma	3.37e-06	0.00014	CbGpPWpGaD
